tiprankstipranks
Advertisement

RESM - ETF AI Analysis

Compare

Top Page

RESM

Columbia Research Enhanced Small Cap ETF (RESM)

Rating:65Neutral
Price Target:
RESM, the Columbia Research Enhanced Small Cap ETF, earns a solid overall rating largely because several core holdings like CareTrust REIT (CTRE), Old National Bancorp (ONB), InterDigital (IDCC), and UMB Financial (UMBF) show strong financial performance, healthy growth, and generally positive outlooks. These strengths are partly offset by holdings such as ViaSat (VSAT), JFrog (FROG), Glaukos (GKOS), and BrightSpring (BTSG), where high leverage, profitability challenges, and valuation concerns introduce more risk. The main risk factor for the fund is its exposure to smaller companies with mixed profitability and some overbought technical signals, which can make returns more volatile.
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the last few months, indicating solid recent momentum.
Solid Top Holdings
Many of the largest positions, including companies in technology, health care, and financials, have delivered strong year-to-date performance that supports the fund’s returns.
Broad Sector Diversification
The fund is spread across many sectors such as health care, technology, financials, industrials, and real estate, which helps reduce the impact if any single industry struggles.
Negative Factors
Small Asset Base
The ETF manages a relatively small amount of assets, which can make it more vulnerable to large investor inflows or outflows and may affect trading liquidity.
High U.S. Concentration
With almost all of its holdings in U.S. companies, the fund offers very limited international diversification and is heavily tied to the U.S. market.
Moderate Expense Ratio
The fund’s fees are not extremely high but are also not among the lowest, meaning a modest portion of returns goes toward covering costs each year.

RESM vs. SPDR S&P 500 ETF (SPY)

RESM Summary

The Columbia Research Enhanced Small Cap ETF (RESM) focuses on smaller U.S. companies, aiming for long-term growth by using research to pick promising stocks rather than tracking a specific index. It spreads investments across many sectors like health care, technology, and financials, and holds companies such as UMB Financial and JFrog. Someone might invest in RESM to tap into the growth potential of emerging businesses while adding diversification beyond large, well-known firms. A key risk is that small-cap stocks can be more volatile, so the ETF’s value can go up and down more sharply with the market.
How much will it cost me?This ETF has an expense ratio of 0.32%, which means you’ll pay about $3.20 per year for every $1,000 invested. That’s a bit higher than the average index ETF because it’s actively managed using research-driven stock selection rather than simply tracking a basic small-cap index.
What would affect this ETF?This U.S. small-cap ETF could benefit if the American economy stays healthy, interest rates eventually ease, and demand remains strong in areas like technology, health care, and industrials, which make up a large part of its holdings. On the other hand, small-cap stocks can be hit hard by higher borrowing costs, economic slowdowns, or tighter regulations, and company-specific setbacks in key holdings like Fabrinet or Sterling Infrastructure could also weigh on performance.

RESM Top 10 Holdings

RESM is leaning into U.S. small caps with a mix of rising niche players and a few names losing steam. Tech and aerospace stand out, with Moog and ViaSat powering performance thanks to strong momentum and growth stories, while JFrog adds a fast-growing, if still unprofitable, software angle. Health care is another key engine: Glaukos and BrightSpring are climbing, though their rich valuations and profitability issues could inject some volatility. Financials like UMB Financial and Old National Bancorp provide steadier ballast, helping smooth out the bumps in this domestically focused, research-driven small-cap ride.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
JFrog0.58%$35.47K$12.83B100.00%
73
Outperform
UMB Financial0.52%$31.94K$10.98B18.61%
77
Outperform
ViaSat0.50%$30.47K$10.02B108.38%
56
Neutral
Moog0.49%$30.28K$12.13B92.93%
73
Outperform
Glaukos0.48%$29.29K$10.73B87.72%
61
Neutral
CareTrust REIT0.46%$28.10K$9.30B14.22%
80
Outperform
FirstCash0.45%$27.78K$9.72B48.85%
74
Outperform
InterDigital0.45%$27.44K$8.64B23.16%
76
Outperform
Old National Bancorp Capital0.44%$27.27K$9.89B13.53%
80
Outperform
BrightSpring Health Services, Inc.0.43%$26.43K$12.05B156.64%
67
Neutral

RESM Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
24.28
Positive
100DMA
23.45
Positive
200DMA
Market Momentum
MACD
0.07
Positive
RSI
46.90
Neutral
STOCH
19.79
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RESM, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 24.58, equal to the 50-day MA of 24.28, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.07 indicates Positive momentum. The RSI at 46.90 is Neutral, neither overbought nor oversold. The STOCH value of 19.79 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for RESM.

RESM Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$6.14M0.32%
65
Neutral
$90.24M0.75%
64
Neutral
$82.09M0.64%
66
Neutral
$68.27M0.61%
65
Neutral
$37.20M0.49%
65
Neutral
$26.29M0.86%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RESM
Columbia Research Enhanced Small Cap ETF
24.29
3.95
19.42%
AIMS
Acuitas Small Cap Active ETF
RUSC
US Small Cap Equity Active ETF
SYZ
Lazard US Systematic Small Cap Equity ETF
ESSC
Eventide Small Cap ETF
FTKI
First Trust Small Cap BuyWrite Income ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement